Mechanisms of oxygen inhibition of pulmonary surfactant synthesis.
D000215:Acylation; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002250:Carbon Radioisotopes; D002794:Choline / Q000037:antagonists & inhibitors / Q000378:metabolism; D002855:Chromatography, Thin Layer; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006207:Half-Life; D006931:Hyperbaric Oxygenation; D008168:Lung / Q000201:enzymology; D008244:Lysophosphatidylcholines / Q000378:metabolism; D010100:Oxygen / Q000633:toxicity*; D010169:Palmitic Acids / Q000037:antagonists & inhibitors / Q000378:metabolism; D010713:Phosphatidylcholines / Q000096:biosynthesis* / Q000302:isolation & purification; D011650:Pulmonary Alveoli / Q000187:drug effects*; D011663:Pulmonary Surfactants / Q000096:biosynthesis*; D011817:Rabbits; D051381:Rats; D013347:Subcellular Fractions; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D005231:Fatty Acids, Unsaturated; D008244:Lysophosphatidylcholines; D010169:Palmitic Acids; D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D014316:Tritium; D002794:Choline; D010100:Oxygen